Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Small Cell Lung Carcinoma 4Recurrence 4Ovarian Neoplasms 3Lymphoma, Non-Hodgkin 2Triple Negative Breast Neoplasms 1Solid Tumors 1Sarcoma 1Hereditary Sensory and Autonomic Neuropathies 1Carcinoma, Hepatocellular 1

Interventions

Etoposide 154Carboplatin 142Cisplatin 104Topotecan 74durvalumab 48atezolizumab 46Irinotecan 44pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 29anlotinib 23PM 01183 22Gemcitabine 21Drug Therapy 20apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Bevacizumab 13amrubicin 11Magnetic Resonance Spectroscopy 11Cyclophosphamide 11rovalpituzumab tesirine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Small Cell Lung Carcinoma × chiauranib × Clear all
NCT04830813 2024-12-09

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 3 Completed
184 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05271292 2024-07-16

SCLC

Chipscreen Biosciences, Ltd.

Phase 1/2 Recruiting
36 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed
6 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03216343 2023-08-30

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 1 Completed
48 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡